FDA 483 - Targeted Genomics, LLC - March 26, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Targeted Genomics, LLC in Irvine, CA, a manufacturer of genetic testing kits, revealed two significant observations. The firm failed to apply a risk-based approach to its quality management system, specifically lacking a required FMEA for its Class II GlutenID Genetic Health Risk Test. Additionally, controls over outsourced processes for assembling and distributing genetic testing kits were not proportionate to the risk, with inadequate supplier qualification and monitoring procedures for a critical supplier.
ID · 4da76e2d-ebd6-436e-a47c-87990340c59d